Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy
From MaRDI portal
Publication:2678792
DOI10.1016/j.jtbi.2022.111394zbMath1506.92050OpenAlexW4312116182MaRDI QIDQ2678792
Brock D. Sherlock, Adelle C. F. Coster
Publication date: 24 January 2023
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2022.111394
Related Items (1)
Cites Work
- Modeling and analysis of a virus that replicates selectively in tumor cells
- Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
- A family of embedded Runge-Kutta formulae
- Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
- ODE models for oncolytic virus dynamics
- Optimizing the timing and composition of therapeutic phage cocktails: a control-theoretic approach
- Oncolytic virotherapy for tumours following a Gompertz growth law
- Population models with singular equilibrium
This page was built for publication: Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy